These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 29603593)
1. Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Place AE; Pikman Y; Stevenson KE; Harris MH; Pauly M; Sulis ML; Hijiya N; Gore L; Cooper TM; Loh ML; Roti G; Neuberg DS; Hunt SK; Orloff-Parry S; Stegmaier K; Sallan SE; Silverman LB Pediatr Blood Cancer; 2018 Jul; 65(7):e27062. PubMed ID: 29603593 [TBL] [Abstract][Full Text] [Related]
2. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Trucco M; Barredo JC; Goldberg J; Leclerc GM; Hale GA; Gill J; Setty B; Smith T; Lush R; Lee JK; Reed DR Pediatr Blood Cancer; 2018 Sep; 65(9):e27224. PubMed ID: 29856514 [TBL] [Abstract][Full Text] [Related]
3. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Abshire TC; Pollock BH; Billett AL; Bradley P; Buchanan GR Blood; 2000 Sep; 96(5):1709-15. PubMed ID: 10961868 [TBL] [Abstract][Full Text] [Related]
4. A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Daver N; Boumber Y; Kantarjian H; Ravandi F; Cortes J; Rytting ME; Kawedia JD; Basnett J; Culotta KS; Zeng Z; Lu H; Richie MA; Garris R; Xiao L; Liu W; Baggerly KA; Jabbour E; O'Brien S; Burger J; Bendall LJ; Thomas D; Konopleva M Clin Cancer Res; 2015 Jun; 21(12):2704-14. PubMed ID: 25724525 [TBL] [Abstract][Full Text] [Related]
5. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib. August KJ; Guest EM; Lewing K; Hays JA; Gamis AS Pediatr Blood Cancer; 2020 Mar; 67(3):e28062. PubMed ID: 31724803 [TBL] [Abstract][Full Text] [Related]
6. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial. Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464 [TBL] [Abstract][Full Text] [Related]
7. Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. Raetz EA; Borowitz MJ; Devidas M; Linda SB; Hunger SP; Winick NJ; Camitta BM; Gaynon PS; Carroll WL J Clin Oncol; 2008 Aug; 26(24):3971-8. PubMed ID: 18711187 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas. Kim SJ; Shin DY; Kim JS; Yoon DH; Lee WS; Lee H; Do YR; Kang HJ; Eom HS; Ko YH; Lee SH; Yoo HY; Hong M; Suh C; Kim WS Ann Oncol; 2016 Apr; 27(4):712-8. PubMed ID: 26861608 [TBL] [Abstract][Full Text] [Related]
9. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. Koh KN; Im HJ; Kim H; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Lim YT; Park JE; Park BK; Park HJ; Seo JJ J Korean Med Sci; 2017 Apr; 32(4):642-649. PubMed ID: 28244291 [TBL] [Abstract][Full Text] [Related]
10. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; Camitta BM J Pediatr Hematol Oncol; 2011 Dec; 33(8):610-6. PubMed ID: 22042277 [TBL] [Abstract][Full Text] [Related]
11. Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study. Burke MJ; Kostadinov R; Sposto R; Gore L; Kelley SM; Rabik C; Trepel JB; Lee MJ; Yuno A; Lee S; Bhojwani D; Jeha S; Chang BH; Sulis ML; Hermiston ML; Gaynon P; Huynh V; Verma A; Gardner R; Heym KM; Dennis RM; Ziegler DS; Laetsch TW; Oesterheld JE; Dubois SG; Pollard JA; Glade-Bender J; Cooper TM; Kaplan JA; Farooqi MS; Yoo B; Guest E; Wayne AS; Brown PA Clin Cancer Res; 2020 May; 26(10):2297-2307. PubMed ID: 31969338 [TBL] [Abstract][Full Text] [Related]
12. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance. Yeo KK; Gaynon PS; Fu CH; Wayne AS; Sun W J Pediatr Hematol Oncol; 2016 Jul; 38(5):345-9. PubMed ID: 27352191 [TBL] [Abstract][Full Text] [Related]
14. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991 [TBL] [Abstract][Full Text] [Related]
15. A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Nelken B; Cave H; Leverger G; Galambrun C; Plat G; Schmitt C; Thomas C; Vérité C; Brethon B; Gandemer V; Bertrand Y; Baruchel A; Rohrlich P Pediatr Blood Cancer; 2016 Feb; 63(2):270-5. PubMed ID: 26376115 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893 [TBL] [Abstract][Full Text] [Related]
17. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study. Buchanan GR; Rivera GK; Boyett JM; Chauvenet AR; Crist WM; Vietti TJ Blood; 1988 Oct; 72(4):1286-92. PubMed ID: 3167209 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium. Messinger Y; Gaynon P; Raetz E; Hutchinson R; Dubois S; Glade-Bender J; Sposto R; van der Giessen J; Eckroth E; Bostrom BC Pediatr Blood Cancer; 2010 Aug; 55(2):254-9. PubMed ID: 20582937 [TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors. Park SR; Kim JH; Kim DY; Lee S; Lee SY; Choi IS; Yoon SS; Park S; Kim BG; Kim NK Korean J Intern Med; 2003 Mar; 18(1):21-8. PubMed ID: 12760264 [TBL] [Abstract][Full Text] [Related]
20. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia]. Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]